FJ Labs

FJ Labs is a New York-based stage-agnostic venture firm founded by Fabrice Grin and Jose Marin, deploying $1M-$5M cheques at Seed, Series A, and Series B with a high-velocity portfolio approach and global mandate that includes digital health investments in Indian and emerging-market startups. The firm operates with a distinctive approach: extremely fast decisions (often within two meetings), small-to-mid cheques, and a willingness to follow strong leads in many jurisdictions. For founders, FJ Labs is best positioned as a fast-moving co-investor that travels well across global markets, particularly useful when speed and brand signal are valuable but a deep healthcare specialist is not the primary need. The right founder profile is an operator (anywhere in the world, with notable Indian and Latin American presence) building a digital health or marketplace-style platform with strong unit economics, capital efficiency, and a clear path to scale. Founders building deep clinical AI requiring deep technical underwriting, biotech, or asset-heavy hospital chains are a poor fit. The cleanest entry path is via FJ Labs’ open application portal, prior portfolio founders, or warm introductions from any of the dozens of co-investing global VCs that frequently syndicate with the firm. In the pitch, lead with capital efficiency, marketplace dynamics or unit economics, named customer or transaction logos, and a credible plan that does not depend on FJ Labs’ technical diligence. Caveats: AI focus is not stated and the firm is generalist, so AI-heavy founders should not expect deep technical underwriting. FJ Labs typically does not lead rounds and prefers to follow a credible lead, so founders should secure their lead investor first. Term sheets are standard and partners are not deeply hands-on operationally; treat FJ Labs as additive capital rather than primary partnership.